The injectable drug Ozempic is displayed, July 1, 2023, in Houston. Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices. (AP Photo/David J. Phillip, File)